DZ Bank’s AnaptysBio ANAB Stock Holding History

DZ Bank’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.67M	Buy	+83,942	New	+$5.09M	﹤0.01%	493
2018 Q2	–	Sell	-3,698	Closed	-$385K	–	859
2018 Q1	$385K	Buy	+3,698	New	+$417K	﹤0.01%	833

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DZ Bank's ANAB Position: Q2 2026 in Review

DZ Bank opened a new position in AnaptysBio (ANAB) in Q2 2026: 83,942 shares worth $5.67M. The stake represents ﹤0.01% of the portfolio and ranks #493 among its holdings. This is a return to the name: DZ Bank previously reported a position in ANAB as recently as Q1 2018.

DZ Bank first reported a position in ANAB in Q1 2018 and has held it in 2 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

DZ Bank held 83,942 shares of AnaptysBio worth $5.67M as of Q2 2026.
AnaptysBio was a new DZ Bank position in Q2 2026.
AnaptysBio made up ﹤0.01% of DZ Bank's portfolio in Q2 2026, its #493 holding.
DZ Bank first reported a position in AnaptysBio in Q1 2018 and has held it in 2 quarters since.
213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.